Literature DB >> 21615745

Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk.

Craig Jenkins1, Sandra Ramírez-Arcos, Mindy Goldman, Dana V Devine.   

Abstract

BACKGROUND: Bacterial contamination of platelet components (PCs) remains an important cause of transfusion-associated infectious risk. In 2004, Canadian Blood Services (CBS) implemented bacterial testing of PCs using the BacT/ALERT 3D system (bioMérieux). This system has been validated and implemented and continuous monitoring of culture rates allows gathering of data regarding true and false positives as well as false negatives. STUDY DESIGN AND METHODS: National data gathered between March 2004 and October 2010 from 12 CBS sites were analyzed to compare bacterial contamination rates across three platelet (PLT) preparation methods: apheresis, buffy coat, and PLT-rich plasma. Data were compared before and after implementation of protocol changes that may affect bacterial detection or contamination rates.
RESULTS: Initial positive rates among the three production methods were significantly different, with apheresis PCs being the highest. The rates of confirmed positives among production methods did not differ significantly (p = 0.668). Increasing sample testing volumes from 4 to 6 mL to 8 to 10 mL significantly increased the rate of initial positives, while confirmed positives increased from 0.64 to 1.63 per 10,000, approaching significance (p = 0.055). Changing the skin disinfection method from a two-step to a one-step protocol did not significantly alter the rate of confirmed positives. During the period of data analysis, eight false-negative cases were reported, with five implicated in adverse transfusion reactions.
CONCLUSION: Bacterial testing of PCs and implementation of improved protocols are incrementally effective in reducing the risk of transfusion of bacterially contaminated PLT concentrates; however, the continued occurrence of false-negative results means the risk has not been eliminated.
© 2011 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2011        PMID: 21615745     DOI: 10.1111/j.1537-2995.2011.03187.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  9 in total

1.  Financial impact of alternative approaches to reduce bacterial contamination of platelet transfusions.

Authors:  Seema Kacker; Evan M Bloch; Paul M Ness; Eric A Gehrie; Christi E Marshall; Parvez M Lokhandwala; Aaron A R Tobian
Journal:  Transfusion       Date:  2019-01-08       Impact factor: 3.157

Review 2.  Toward in Vitro Production of Platelet from Induced Pluripotent Stem Cells.

Authors:  Elaheh Izady; Zohreh Saltanatpour; Li-Ping Liu; Akram Alizadeh; Amir Ali Hamidieh
Journal:  Stem Cell Rev Rep       Date:  2022-04-09       Impact factor: 6.692

3.  Nationwide Implementation of Pathogen Inactivation for All Platelet Concentrates in Switzerland.

Authors:  Markus Jutzi; Behrouz Mansouri Taleghani; Morven Rueesch; Lorenz Amsler; Andreas Buser
Journal:  Transfus Med Hemother       Date:  2018-05-23       Impact factor: 3.747

Review 4.  Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion.

Authors:  Daniel Tzu-Bi Shih; Thierry Burnouf
Journal:  N Biotechnol       Date:  2014-06-11       Impact factor: 5.079

5.  Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen-reduced platelets.

Authors:  Burak Bahar; Wade L Schulz; Amit Gokhale; Bryan R Spencer; Eric A Gehrie; Edward L Snyder
Journal:  Br J Haematol       Date:  2019-09-30       Impact factor: 6.998

6.  An Internal Reference Control Duplex Real-Time Polymerase Chain Reaction Assay for Detecting Bacterial Contamination in Blood Products.

Authors:  Jin-Ju Zhang; Jing-Jing Tian; Shuang-Shi Wei; Sheng-Bao Duan; Hong-Mei Wang; Ye-Zhou Chen; Shao-Hua Ding; Chun Zhang; Qing-Lin Meng; Yong Li
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

7.  Process improvement by eliminating mixing of whole blood units after an overnight hold prior to component production using the buffy coat method.

Authors:  Cherie Mastronardi; Peter Schubert; Elena Levin; Varsha Bhakta; Qi-Long Yi; Adele Hansen; Tamiko Stewart; Craig Jenkins; Wanda Lefresne; William Sheffield; Jason P Acker
Journal:  J Blood Transfus       Date:  2013-06-05

8.  The peptidoglycan and biofilm matrix of Staphylococcus epidermidis undergo structural changes when exposed to human platelets.

Authors:  Maria Loza-Correa; Juan A Ayala; Iris Perelman; Keith Hubbard; Miloslav Kalab; Qi-Long Yi; Mariam Taha; Miguel A de Pedro; Sandra Ramirez-Arcos
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

9.  Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation.

Authors:  Steve Kleinman; Adonis Stassinopoulos
Journal:  Transfusion       Date:  2015-08-25       Impact factor: 3.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.